Respiratory Syncytial Viruses
"Respiratory Syncytial Viruses" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.
| Descriptor ID |
D012136
|
| MeSH Number(s) |
B04.820.455.600.670.600.750
|
| Concept/Terms |
Respiratory Syncytial Viruses- Respiratory Syncytial Viruses
- Respiratory Syncytial Virus
- Syncytial Virus, Respiratory
- Syncytial Viruses, Respiratory
- Virus, Respiratory Syncytial
- Viruses, Respiratory Syncytial
Chimpanzee Coryza Agent- Chimpanzee Coryza Agent
- Chimpanzee Coryza Agents
- Coryza Agent, Chimpanzee
- Coryza Agents, Chimpanzee
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Viruses".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Viruses".
This graph shows the total number of publications written about "Respiratory Syncytial Viruses" by people in this website by year, and whether "Respiratory Syncytial Viruses" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Viruses" by people in Profiles.
-
Implementation of a rapid influenza A/B and RSV direct molecular assay improves emergency department oseltamivir use in paediatric patients. J Med Microbiol. 2018 Mar; 67(3):358-363.
-
Inositol-requiring enzyme 1 inhibits respiratory syncytial virus replication. J Biol Chem. 2014 Mar 14; 289(11):7537-46.
-
Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol. 2013 Apr 15; 304(8):L530-9.
-
Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis. Pediatr Crit Care Med. 2011 Sep; 12(5):580-8.
-
Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children. Curr Med Res Opin. 2010 Sep; 26(9):2175-81.
-
Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation. Virology. 2010 Oct 25; 406(2):241-52.
-
Does the viral subtype influence the biennial cycle of respiratory syncytial virus? Virol J. 2009 Sep 07; 6:133.
-
Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J. 2008 Oct; 27(10 Suppl):S92-6.
-
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol. 2007 Apr; 79(4):447-56.
-
Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007 Apr 15; 195(8):1126-36.